Diantha Duvall
Director of Finance/CFO bij CURIS, INC.
Vermogen: 7 000 $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| James Dentzer | M | 57 | 8 jaar | |
| David I. Stirling | M | - |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 17 jaar |
| Robert Davis | M | 57 | 10 jaar | |
| John Hohneker | M | 64 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 3 jaar |
| Robert Martell | M | 61 | 13 jaar | |
| Nancy Miller-Rich | F | 65 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 8 jaar |
| Martyn Greenacre | M | 82 | 24 jaar | |
| Philippe Drouet | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 3 jaar |
| Mark W. Noel | M | 65 | 23 jaar | |
| William Sibold | M | - | 6 jaar | |
| Chirfi Guindo | M | 58 | 13 jaar | |
| Timothy Harris | M | 74 | 9 jaar | |
| Marc Rubin | M | 69 | 14 jaar | |
| Dalton Smart | M | 58 | 15 jaar | |
| Kenneth Kaitin | M | 71 | 21 jaar | |
| Denise Williams | F | - | 15 jaar | |
| Kimberly Steinmann | M | - | 2 jaar | |
| Dora Ferrari | F | - | 3 jaar | |
| Carol Bowden | F | - | 10 jaar | |
| Nancy Soohoo | F | - | 21 jaar | |
| Reinhard von Roemeling | M | - | 5 jaar | |
| Andre Musto | M | - | 10 jaar | |
| Allan Gabor | M | - | 11 jaar | |
| Robert Michael Platek | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 4 jaar |
| Jonathan Zung | M | 59 | 1 jaar | |
| Philippe Sauvage | M | - | 6 jaar | |
| Sanat Chattopadhyay | M | - | 15 jaar | |
| Kyle W. H. Chan | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 17 jaar |
| Anne Borgman | M | 56 | - | |
| Richard DeLuca | M | 61 | 13 jaar | |
| Louis J. DeGennaro | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | - |
| Rajeev Dadoo | M | 54 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | - |
| Peter N. Crnkovich | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 5 jaar |
| Jeffrey Edwards | M | 64 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 5 jaar |
| Rachel Blasbalg | F | - | 20 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 100 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Diantha Duvall
- Persoonlijk netwerk
